-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $40

Benzinga·05/08/2026 13:24:34
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $42 to $40.